-
1 Comment
China Isotope & Radiation Corporation is currently in a long term uptrend where the price is trading 12.4% above its 200 day moving average.
From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
China Isotope & Radiation Corporation's total revenue rose by 18.1% to $3B since the same quarter in the previous year.
Its net income has dropped by 21.8% to $142M since the same quarter in the previous year.
Finally, its free cash flow grew by 133.4% to $95M since the same quarter in the previous year.
Based on the above factors, China Isotope & Radiation Corporation gets an overall score of 4/5.
| Industry | Medical Devices |
|---|---|
| Sector | Healthcare |
| ISIN | CNE1000031F4 |
| CurrencyCode | HKD |
| Exchange | HK |
| Market Cap | 5B |
|---|---|
| Beta | 0.84 |
| Dividend Yield | 2.6% |
| Target Price | 33.56 |
| PE Ratio | 13.66 |
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services, and Other Business segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1763.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
